CLINICAL_TRIALS
trial_result
· 2024-01-30
Clinical Trial Update: Feasibility Study of the FARAPULSE Endocardial Multi Ablation System in the Treatment of Persistent Atrial Fibrillation [NA]
Summary
Feasibility study completion for the FARAPULSE endocardial multi ablation system in persistent atrial fibrillation with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boston Scientific Corporation | Conditions: Persistent Atrial Fibrillation | NA | Status: COMPLETED | Results posted: 2024-01-30